KERYX BIOPHARMACEUTICALS INC

CUSIP: 492515101 Class: COMMON STOCK

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q3 2018
Shares 51,534 Value ($000) $175 Avg Close — Range —
Q2 2018
Shares 62,564 Value ($000) $235 Avg Close — Range —
Q1 2018
Shares 231,934 Value ($000) $949 Avg Close — Range —
Q4 2017
Shares 102,638 Value ($000) $477 Avg Close — Range —
Q3 2017
Shares 105,302 Value ($000) $747 Avg Close — Range —
Q2 2017
Shares 188,150 Value ($000) $1,360 Avg Close — Range —
Q1 2017
Shares 264,588 Value ($000) $1,630 Avg Close — Range —
Q4 2016
Shares 236,172 Value ($000) $1,384 Avg Close — Range —
Q3 2016
Shares 291,757 Value ($000) $1,549 Avg Close — Range —
Q2 2016
Shares 348,144 Value ($000) $2,305 Avg Close — Range —
Q1 2016
Shares 388,535 Value ($000) $1,814 Avg Close — Range —
Q4 2015
Shares 464,405 Value ($000) $2,345 Avg Close — Range —
Q3 2015
Shares 476,608 Value ($000) $1,678 Avg Close — Range —
Q2 2015
Shares 249,979 Value ($000) $2,495 Avg Close — Range —
Q1 2015
Shares 336,362 Value ($000) $4,281 Avg Close — Range —
Q4 2014
Shares 170,823 Value ($000) $2,417 Avg Close — Range —